A short course of antibiotics is effective for treating pneumonia in childrenBMJ 2022; 378 doi: https://doi.org/10.1136/bmj.o1767 (Published 05 August 2022) Cite this as: BMJ 2022;378:o1767
- Helen Saul, editor in chief1,
- Deniz Gursul, research dissemination manager1,
- Samantha Cassidy, science writer1 ,
- Julia Bielicki, lecturer2
- Correspondence to H Saul
Barratt S, Bielicki JA, Dunn D, et al. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT. Health Technol Assess 2021;25:60.
To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/short-course-antibiotics-effective-in-childhood-pneumonia/
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.
Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests
All authors contributed to the development and review of this summary, as part of the wider NIHR Alerts editorial team.
More summaries of NIHR research are available at: https://evidence.nihr.ac.uk/alerts/
Disclaimer: NIHR Alerts are owned by the Department of Health and Social Care and are made available to The BMJ under licence. NIHR Alerts report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Alerts.
Permission to reuse these articles should be directed to NIHRAlerts@nihr.ac.uk